In a regulatory filing, JB Chemicals & Pharmaceuticals said the NGT (West Zone) has via order dated January 8, 2016 termed the environmental clearance given to it by the Centre as "illegal" and "directed the Government of India to revoke within one month the environment clearance granted to the company's plant".
Consequently, the NGT has also "directed the company to close down the activities at the said plant within four weeks", it added.
JB Chemicals, however, said it has been operating the plant with a valid environmental clearance which was accorded to the plant by the Ministry of Environment and Forest in January 1994.
"The company plans to immediately appeal the said order in the Supreme Court and is confident that the Court will grant relief to the company especially in light of various technical and factual aspects involved in the matter," it said.
The NGT order has come after the Paryavartan Suraksha Samiti, Vododara and Peoples Union for Civil Liberties, Ankleshwar challenged the said environment clearance to the manufacturing facility.
During 2014-15, the total sale of bulk drugs manufactured at the said plant amounted to Rs 104 crore. Besides, the company also uses active pharmaceutical ingredients (APIs) produced at this plant for captive consumption.
JB Chemicals & Pharmaceuticals' stock was trading at Rs 263.55, down 3.66 per cent, on the BSE.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
)